DJIA 18,288.63 155.93 0.86%
NASDAQ 5,008.10 44.57 0.90%
S&P 500 2,117.39 12.89 0.61%
market minute promo

MannKind Corp (NASDAQ: MNKD)

6.64 0.12 (1.84%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

MNKD $6.64 1.84%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $6.50
Previous Close $6.52
Daily Range $6.45 - $6.75
52-Week Range $3.80 - $11.48
Market Cap $2.7B
P/E Ratio -12.78
Dividend (Yield) $0.00 (0.0%)
Volume 6,073,957
Average Daily Volume 6,426,180
Current FY EPS -$0.34




Drug Makers

MannKind Corp (MNKD) Description

A biopharmaceutical company focused on the development and commercialization of therapeutic products for diseases such as diabetes and cancer. Website:

News & Commentary

Why Second Sight Medical Products Inc. Vaulted Higher Today

Second Sight Medical Products shares continue to surge higher.

Institutions Lend Out MannKind Shares To Make Profits But Depress The Price As Well

MannKind's Afrezza Earns Lackluster Review from Independent Drug Arbiter

Analysts Weigh In On MannKind Following Q4 Results

Analysts Weigh in on MannKind Following Q4 Results

MannKind's Financial Statements Can Be Scary To Most Investors

Are Sellers Wrong to Be Short MannKind Corp.?

MannKind Corporation's short interest has soared to more than 80 million shares.

An Objective, We Think, Up-To-Date Look At MannKind

Jefferies Expects Exciting 2015 For MannKind

More Insight Into MannKind's Near-Term Profitability

See More MNKD News...

MNKD's Top Competitors

MNKD $6.64 (1.84%)
Current stock: MNKD
AMGN $159.63 (1.21%)
Current stock: AMGN
CELG $120.31 (-1.00%)
Current stock: CELG
GILD $103.83 (0.29%)
Current stock: GILD